secwatch.observer — SEC 8-K summary
======================================

Issuer:     Coya Therapeutics, Inc. (COYA)
CIK:        0001835022
Form:       8-K
Filed at:   2023-03-01T23:59:59+00:00
Accession:  0001193125-23-056314
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Coya Therapeutics grants stock options to CEO, President/CMO, and CFO/COO
-------------------------------------------------------------------------

- CEO Howard Berman granted options to purchase 165,000 shares at $3.85 per share.
- President/CMO Adrian Hepner and CFO/COO David Snyder each granted options for 115,000 shares.
- Options vest in 36 equal monthly installments with full acceleration on change of control.
- Options expire 10 years from grant date; exercise price equals closing price on grant date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835022/000119312523056314/0001193125-23-056314-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835022/000119312523056314/d476471d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-056314

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer